142 related articles for article (PubMed ID: 8264116)
1. [Basic study of CA125 measurement using a newly developed "SD-8729" IRMA kit].
Yamaguchi A; Kobayashi M; Imai T; Otake H; Matsubara K; Hatori N; Tomiyoshi K; Inoue T; Endo K
Kaku Igaku; 1993 Oct; 30(10):1245-52. PubMed ID: 8264116
[TBL] [Abstract][Full Text] [Related]
2. [Basic studies of BALL ELSA CA125-II KIT for detection of serum cancer antigen 125].
Kakizaki J; Miyazaki T; Maeda T
Kaku Igaku; 1993 Jul; 30(7):807-12. PubMed ID: 8377304
[TBL] [Abstract][Full Text] [Related]
3. [Basic and clinical studies of serum CA195 antigen assay with "BL-CA195" kit].
Kobayashi M; Yamaguchi A; Imai T; Otake H; Igarashi H; Hatori N; Tomiyoshi K; Inoue T; Endo K; Sakahara H
Kaku Igaku; 1993 Apr; 30(4):441-7. PubMed ID: 8315895
[TBL] [Abstract][Full Text] [Related]
4. Construction of an immunoradiometric assay for ovarian cancer associated antigen CA125 recognizing different antigenic determinant.
Saga T; Endo K; Nakashima T; Awaji T; Koizumi M; Kawamura Y; Watanabe Y; Konishi J; Nonogaki H; Nanbu Y
Acta Obstet Gynecol Scand; 1990; 69(2):175-81. PubMed ID: 1696770
[TBL] [Abstract][Full Text] [Related]
5. [A basic and clinical evaluation of a new immunoradiometric assay kit for human serum tissue polypeptide antigen (TPA)].
Shimojo K; Watanabe N; Sakai S; Kobayashi M; Ohtake H; Hatori N; Fukasawa K; Tomiyoshi K; Inoue T; Endo K
Kaku Igaku; 1996 Jun; 33(6):655-61. PubMed ID: 8741511
[TBL] [Abstract][Full Text] [Related]
6. [The preparation and clinical use of a radioimmunoassay CA125 kit for the diagnosis of epithelial ovarian cancer].
Liu W
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1992 Dec; 14(6):469-72. PubMed ID: 1303823
[TBL] [Abstract][Full Text] [Related]
7. Development of new immunoradiometric assay for CA 125 antigen using two monoclonal antibodies produced by immunizing lung cancer cells.
Kunimatsu M; Endo K; Nakashima T; Awaji T; Saga T; Watanabe Y; Kawamura Y; Ohta H; Koizumi M; Sakahara H
Ann Nucl Med; 1988 Nov; 2(2):73-9. PubMed ID: 3275111
[TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation of new cancer-associated antigen CA125 II in epithelial ovarian cancers: comparison with CA125.
Kobayashi H; Tamura M; Satoh T; Terao T
Clin Biochem; 1993 Jun; 26(3):213-9. PubMed ID: 8330391
[TBL] [Abstract][Full Text] [Related]
9. [A fundamental and clinical investigation of cancer antigen 130 (CA 130) in the field of obstetrics and gynecology].
Inaba N; Okajima Y; Ota Y; Fukazawa I; Yamaguchi T; Sato N; Sudo H; Milanga M; Takamizawa H; Fujii S
Nihon Gan Chiryo Gakkai Shi; 1989 Oct; 24(10):2426-35. PubMed ID: 2614181
[TBL] [Abstract][Full Text] [Related]
10. Dissociation in serum CA125 concentrations measured by different monoclonal antibodies.
Sakahara H; Kousaka T; Hattori N; Tomida K; Yao Z; Hosono M; Kobayashi H; Shirato M; Endo K; Konishi J
Gynecol Oncol; 1994 Mar; 52(3):301-5. PubMed ID: 7512519
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of a cytokeratin 19 assay kit "BALL ELSA CYFRA21-1"].
Sakahara H; Kousaka T; Hattori N; Hosono M; Kobayashi H; Shirato M; Yao Z; Konishi J
Kaku Igaku; 1993 Dec; 30(12):1475-9. PubMed ID: 7509008
[TBL] [Abstract][Full Text] [Related]
12. Characterization of CA125 glycoprotein using 3 monoclonal antibodies with different specificities.
Kobayashi F; Sagawa N; Fujii S; Mori T; Endo K
Gynecol Obstet Invest; 1994; 37(3):199-203. PubMed ID: 8005553
[TBL] [Abstract][Full Text] [Related]
13. An approach for immunoradiometric assay with metallic radionuclides: gallium-67-deferoxamine-dialdehyde starch-IgG.
Furukawa T; Fujibayashi Y; Fukunaga M; Saga T; Endo K; Yokoyama A
J Nucl Med; 1991 May; 32(5):825-9. PubMed ID: 2022990
[TBL] [Abstract][Full Text] [Related]
14. Characterisation and clinical usefulness of CA130 antigen recognised by monoclonal antibodies, 130-22 and 145-9, in ovarian cancers.
Kobayashi H; Ohi H; Fujii T; Terao T
Br J Cancer; 1993 Feb; 67(2):237-43. PubMed ID: 7679280
[TBL] [Abstract][Full Text] [Related]
15. Recognition of ovarian cancer antigen CA125 by murine monoclonal antibody produced by immunization of lung cancer cells.
Matsuoka Y; Nakashima T; Endo K; Yoshida T; Kunimatsu M; Sakahara H; Koizumi M; Nakagawa T; Yamaguchi N; Torizuka K
Cancer Res; 1987 Dec; 47(23):6335-40. PubMed ID: 3315184
[TBL] [Abstract][Full Text] [Related]
16. [Basic and clinical studies on SPan-1 RIABEAD kit: usefulness in patients with pancreatic and biliary tract cancer].
Watanabe Y; Endo K; Nakajima K; Hattori N; Sakahara H; Saga T; Nakai T; Hosono M; Yao ZS; Baba N
Kaku Igaku; 1989 Dec; 26(12):1559-65. PubMed ID: 2622087
[No Abstract] [Full Text] [Related]
17. [CA125 and radioimmunoimaging in monitoring of epithelial ovarian carcinoma].
Yu Q; Lian LJ
Zhonghua Fu Chan Ke Za Zhi; 1991 Jul; 26(4):235-8, 252. PubMed ID: 1914661
[TBL] [Abstract][Full Text] [Related]
18. An antibody-tumor model for the targeting of CA125-producing gynecologic malignancies.
Saga T; Ishiwata I; Endo K; Sakahara H; Koizumi M; Watanabe Y; Nakai T; Hosono M; Ishikawa H; Sawada M
Jpn J Cancer Res; 1990 Nov; 81(11):1141-8. PubMed ID: 2125039
[TBL] [Abstract][Full Text] [Related]
19. [The evaluation of the newly produced assay kit for the cytokeratin fragment, "ball ELSA CYFRA21-1"].
Kimura Y; Ata M; Nakamura S; Fujii T; Kawamura T; Tanada S; Hamamoto K
Kaku Igaku; 1994 Feb; 31(2):199-206. PubMed ID: 7509886
[TBL] [Abstract][Full Text] [Related]
20. Discordant serum CA 125 values in commercial immunoassays.
van Kamp GJ; Verstraeten AA; Kenemans P
Eur J Obstet Gynecol Reprod Biol; 1993 Apr; 49(1-2):99-103. PubMed ID: 8365530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]